These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15899246)

  • 1. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
    Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
    Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
    Peng S; Wuu J; Mufson EJ; Fahnestock M
    J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
    Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
    Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Neuropsychobiology; 2007; 55(3-4):151-5. PubMed ID: 17657167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease.
    Fehér A; Juhász A; Rimanóczy A; Kálmán J; Janka Z
    Alzheimer Dis Assoc Disord; 2009; 23(3):224-8. PubMed ID: 19812463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.
    Culpan D; Cram D; Chalmers K; Cornish A; Palmer L; Palmer J; Hughes A; Passmore P; Craig D; Wilcock GK; Kehoe PG; Love S
    Neurobiol Aging; 2009 Jul; 30(7):1052-60. PubMed ID: 18069092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
    Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
    J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
    Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
    Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan.
    Akatsu H; Yamagata HD; Kawamata J; Kamino K; Takeda M; Yamamoto T; Miki T; Tooyama I; Shimohama S; Kosaka K
    Dement Geriatr Cogn Disord; 2006; 22(3):216-22. PubMed ID: 16899999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
    Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
    Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
    Tannenberg RK; Scott HL; Tannenberg AE; Dodd PR
    Neurochem Int; 2006 Dec; 49(7):631-9. PubMed ID: 16814428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.
    Tsai SJ; Hong CJ; Liu HC; Liu TY; Liou YJ
    Dement Geriatr Cogn Disord; 2006; 21(3):139-43. PubMed ID: 16391475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
    Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S
    Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.